E. Ohman J:Or Asset Management Ab United Therapeutics Corp Transaction History

E. Ohman J:Or Asset Management Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Apr 05, 2024	SELL	$101.14 - $118.31 $111,254 - $130,141	-1,100 Closed	0 $0
Q3 2017 Apr 05, 2024	BUY	$114.6 - $136.81 $11,460 - $13,681	100 Added 10.0%	1,100 $129 Million
Q3 2016 Apr 05, 2024	SELL	N/A	-22,556 Reduced 95.75%	1,000 $118 Million
Q2 2016 Apr 05, 2024	BUY	N/A	6,285 Added 36.39%	23,556 $2.5 Billion
Q1 2016 Apr 05, 2024	BUY	N/A	16,271 Added 1627.1%	17,271 $1.92 Billion

Q2 2015 Apr 05, 2024	BUY	N/A	1,000	1,000 $174 Million

561

43.1M

501K

529K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.